Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
AstraZeneca
McKinsey
Harvard Business School
Mallinckrodt

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

QUINAPRIL HYDROCHLORIDE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Quinapril Hydrochloride patents expire, and what generic alternatives are available?

Quinapril Hydrochloride is a drug marketed by Actavis Elizabeth, Actavis Labs Fl Inc, Ani Pharms Inc, Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Lupin, Mylan, Prinston Inc, Sun Pharm Inds Ltd, Yaopharma Co Ltd, Apotex Corp, and Aurobindo Pharma. and is included in eighteen NDAs.

The generic ingredient in QUINAPRIL HYDROCHLORIDE is hydrochlorothiazide; quinapril hydrochloride. There are thirty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.

Drug patent expirations by year for QUINAPRIL HYDROCHLORIDE
Recent Clinical Trials for QUINAPRIL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of NebraskaPhase 4
PfizerN/A
The Hospital for Sick ChildrenPhase 3

See all QUINAPRIL HYDROCHLORIDE clinical trials

Recent Litigation for QUINAPRIL HYDROCHLORIDE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Apotex, Inc. v. Mylan Pharmaceuticals, Inc.2012-04-20
Apotex, Inc. v. UCB, Inc.2012-04-20
Fleetwood Enterprises, Inc.2009-03-10

See all QUINAPRIL HYDROCHLORIDE litigation

Pharmacology for QUINAPRIL HYDROCHLORIDE
Synonyms for QUINAPRIL HYDROCHLORIDE
(3S-(2(R*(R*)),3R*))-2-(2-((1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)AMINO)-1-OXOPROPYL)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACID MONOHYDROCHLORIDE
(3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid Hydrochloride
(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
(3S)-2-[(2S)-2-{[(2S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YL]AMINO}PROPANOYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID HYDROCHLORIDE
(3S)-2-{(2S)-2-[(1S)-1-ethoxycarbonyl-3-phenylpropylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
(3S)-2-{N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
(S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
(S)-2-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-
(S)-2-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
(S)-2-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, 1-ethyl ester, monohydrochloride
(S)-2-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid 1-Ethyl Ester Hydrochloride
[3S-[2[R*(R*)], 3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, monohydrochloride
2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid
2-ylamino)propanoyl)-1,2,3,4-
3-isoquinolineacrboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3S-(2(R*(R*)),3R*))-
3-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, monohydrochloride, (3S-(2(R*(R*)),3R*))-
3-Isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, monohydrochloride, (3S-(2(R*(R*)),3R*))
3-Isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, monohydrochloride, (3S-(2(R*(R*)),3R*))-
3-isoquinolinecarboxylicacid,1,2,3,4-tetrahydro-2-(2-((1-(ethoxycarbonyl)-3-p
33067B3N2M
586Q558
82586-55-8
AB07655
AB2000675
AC-1655
AC1L1HXI
Accupril
Accupril (TN)
Accuprin
Accupro
Accupron
Accuretic
Acequin
Acuitel
Acuprel
AKOS015888532
AN-14706
AS-14026
Asig
BC206223
C07340
C25H30N2O5.HCl
CAS-82586-55-8
CCG-39543
CHEBI:8714
CHEMBL1201011
CI 906
CI-906
CI-906 (CN-109452)
CI906
Conan
Continucor
CPD000499582
CS-2591
D00459
DSSTox_CID_1221
DSSTox_GSID_21221
DSSTox_RID_76019
DTXSID3021221
Ectren
Hemokvin
HMS1922C15
HSDB 7046
HY-B0477
IBBLRJGOOANPTQ-JKVLGAQCSA-N
Korec
Koretic
Lidaltrin
LS-85471
MCULE-2623123657
MFCD00889215
MLS001076683
MolPort-003-666-434
monohydrochloride,(3s-(2(r*(r*)),3r*))-henylpropyl)amino)-1-oxopropyl)
NC00722
NCGC00094997-01
NCGC00167962-06
NCGC00257944-01
NE45380
NSC-758222
NSC758222
PD 109452-2
PD-109,452-2
PD-109522
Pharmakon1600-01503076
Quinapril hydrochloride
Quinapril (hydrochloride)
Quinapril for peak identification, European Pharmacopoeia (EP) Reference Standard
Quinapril for system suitability, European Pharmacopoeia (EP) Reference Standard
QUINAPRIL HCL
Quinapril Hydrochloride ,(S)
Quinapril hydrochloride (Accupril)
Quinapril hydrochloride (JP17/USP)
Quinapril hydrochloride [USAN:USP]
Quinapril hydrochloride [USAN]
quinapril hydrochloride hydrochloride
Quinapril hydrochloride, >=98% (HPLC), solid
Quinapril hydrochloride, European Pharmacopoeia (EP) Reference Standard
Quinapril Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Quinapril hydrochloride, United States Pharmacopeia (USP) Reference Standard
Quinapril hydrochloride;
Quinapril N-Oxide
Quinapril.HCl
Quinazil
s2581
SAM002589972
SC-17215
SCHEMBL41404
SMR000499582
SPECTRUM1503076
SR-01000765404
SR-01000765404-2
SW199393-2
tetrahydroisoquinoline-3-carboxylic
Tox21_111381
Tox21_111381_1
Tox21_200390
UNII-33067B3N2M
Paragraph IV (Patent) Challenges for QUINAPRIL HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
ACCUPRIL TABLET;ORAL quinapril hydrochloride 019885

US Patents and Regulatory Information for QUINAPRIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 076607-001 Dec 15, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 076694-002 Dec 23, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Yaopharma Co Ltd QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 076803-001 Mar 2, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Medtronic
Moodys
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.